These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3825357)

  • 1. [Immunobiological characteristics of impurities in corpuscular influenza vaccines].
    Zhebrun AB; Bichurina MA; Polianskaia NIu; Rozaeva NR; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Dec; (12):52-5. PubMed ID: 3825357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sensitizing action of nonvirion admixtures in inactivated influenza vaccines in an experiment].
    Bichurina MA; Rozaeva NR; Polianskaia NIu; Zhebrun AB; Barashkova LN
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Dec; (12):36-9. PubMed ID: 6528779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improved methods of controlling the purity and activity of inactivated influenza vaccines].
    Noskov FS; Bichurina MA; Zhebrun AB; Polianskaia NIu; Kaplun IIa
    Vopr Virusol; 1985; 30(4):409-13. PubMed ID: 3933181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study of the side effects of the nonvirion admixtures in inactivated influenza vaccines].
    Rozaeva NR; Polianskaia NIu; Bichurina MA; Barashkova LN
    Tr Inst Im Pastera; 1982; 59():121-5. PubMed ID: 7187563
    [No Abstract]   [Full Text] [Related]  

  • 5. [Can formaldehyde, merthiolate and other vaccine components enhance the anaphylactogenicity of ovalbumin present in inactivated influenza vaccines?].
    Reĭzin FN; Matrosovich MN; Chumakov MP; Mart'ianova LI
    Vopr Virusol; 1987; 32(5):615-6. PubMed ID: 3433718
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of the immunochemical purity of modern influenza vaccines].
    Zhebrun AB; Polianskaia NIu; Bichurina MA; Rozaeva NR; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):56-9. PubMed ID: 3799103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Purification of a corpuscular influenza vaccine by means of immunoaffinity chromatography].
    Zhebrun AB; Noskov FS; Polianskaia NIu; Bichurina MA; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jan; (1):45-9. PubMed ID: 3551414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitizing activity to egg protein of an A1PO4-adjuvant full-virus influenza vaccine.
    Nyerges G; Marton A; Korossy S; Vincze I
    Acta Microbiol Acad Sci Hung; 1982; 29(4):245-53. PubMed ID: 7185267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of different methods of determining ovalbumin in preparations of purified influenza virus].
    Bichurina MA; Goriunova VV; Chubarova NI; Zhebruk AB; Noskov FS
    Vopr Virusol; 1981; (2):228-30. PubMed ID: 6791386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laboratory control of the purity of chromatographic influenza vaccine].
    Bichurina MA; Goriunova VV; Zhebrun AB; Chubarova NI
    Tr Inst Im Pastera; 1979; 52():121-8. PubMed ID: 121646
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influenza inhibitor of the host serum RNAse].
    Maksimovich MB
    Vopr Virusol; 1986; 31(5):562-7. PubMed ID: 3798907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-ovalbumin sensitizing ability of influenza vaccines in guinea pigs.
    Weeke-Lüttmann M; Schramm-Thiel N
    Dev Biol Stand; 1977 Jun 1-3; 39():219-222. PubMed ID: 604100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adsorbed subunit influenza vaccine: its isolation and characteristics].
    Shapiro NI; Zhukova TIa; Shpiliuk GF; Entina NN; Konstantinov VK
    Virologie; 1986; 37(2):125-9. PubMed ID: 3727396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral antigens and impurities in influenza vaccines. Evaluation by immunoelectrophoretic methods.
    Liehl E; Bachmayer H
    Dev Biol Stand; 1977 Jun 1-3; 39():163-8. PubMed ID: 564309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovalbumin content in the yellow fever vaccine.
    Smith D; Wong P; Gomez R; White K
    J Allergy Clin Immunol Pract; 2015; 3(5):794-5. PubMed ID: 25912657
    [No Abstract]   [Full Text] [Related]  

  • 16. [An experimental evaluation of the protective and immunogenic activity of an inactivated influenza vaccine under conditions of combined immunization].
    Bichurina MA; Rozaeva NR; Briantseva EA; Titova TS; Kharitonova VA
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):62-3. PubMed ID: 8079571
    [No Abstract]   [Full Text] [Related]  

  • 17. [Development and preclinical study of new generation virosomal split influenza vaccine "Grifor"].
    Mel'nikov SIa; Zverev VV; Korovkin SA; Mironov AN; Dyldina NV; Mikhaĭlova NA; Faĭzuloev EB; Lotte VD
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (1):21-6. PubMed ID: 19338232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenic and reactogenic properties of commercial series of inactivated chromatographic influenza vaccine].
    Peĭsel' SG; Nifontova AI; Zhebrun AB; Karpovich NM; Slatin EA
    Tr Inst Im Pastera; 1979; 52():38-42. PubMed ID: 550545
    [No Abstract]   [Full Text] [Related]  

  • 19. [Properties of liposomal allergens of Neisseria perflava].
    Fedoseeva VN; Barysheva AV
    Biull Eksp Biol Med; 1982 Sep; 94(9):87-90. PubMed ID: 7171830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization and immunological evaluation of alginate nanoparticles loaded with whole inactivated influenza virus: Dry powder formulation for nasal immunization in rabbits.
    Dehghan S; Kheiri MT; Abnous K; Eskandari M; Tafaghodi M
    Microb Pathog; 2018 Feb; 115():74-85. PubMed ID: 29223454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.